508 related articles for article (PubMed ID: 37887287)
21. A novel organic cation transporter involved in paeonol transport across the inner blood-retinal barrier and changes in uptake in high glucose conditions.
Gyawali A; Kim MH; Kang YS
Exp Eye Res; 2021 Jan; 202():108387. PubMed ID: 33301773
[TBL] [Abstract][Full Text] [Related]
22. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation.
Kim JH; Kim JH; Lee YM; Ahn EM; Kim KW; Yu YS
J Cereb Blood Flow Metab; 2009 Sep; 29(9):1559-67. PubMed ID: 19536074
[TBL] [Abstract][Full Text] [Related]
23. AAV-mediated gene delivery in Dp71-null mouse model with compromised barriers.
Vacca O; Darche M; Schaffer DV; Flannery JG; Sahel JA; Rendon A; Dalkara D
Glia; 2014 Mar; 62(3):468-76. PubMed ID: 24382652
[TBL] [Abstract][Full Text] [Related]
24. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions.
Klaassen I; Van Noorden CJ; Schlingemann RO
Prog Retin Eye Res; 2013 May; 34():19-48. PubMed ID: 23416119
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in drug and nutrient transport across the blood-retinal barrier.
Kubo Y; Akanuma SI; Hosoya KI
Expert Opin Drug Metab Toxicol; 2018 May; 14(5):513-531. PubMed ID: 29719158
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid signaling is essential for maintenance of the blood-retinal barrier.
Pollock LM; Xie J; Bell BA; Anand-Apte B
FASEB J; 2018 Oct; 32(10):5674-5684. PubMed ID: 29874129
[TBL] [Abstract][Full Text] [Related]
27. Localization and quantitation of blood-retinal barrier breakdown in experimental proliferative vitreoretinopathy.
Ando N; Sen HA; Berkowitz BA; Wilson CA; de Juan E
Arch Ophthalmol; 1994 Jan; 112(1):117-22. PubMed ID: 8285878
[TBL] [Abstract][Full Text] [Related]
28. Canonical WNT signaling components in vascular development and barrier formation.
Zhou Y; Wang Y; Tischfield M; Williams J; Smallwood PM; Rattner A; Taketo MM; Nathans J
J Clin Invest; 2014 Sep; 124(9):3825-46. PubMed ID: 25083995
[TBL] [Abstract][Full Text] [Related]
29. Adult lead exposure increases blood-retinal permeability: A risk factor for retinal vascular disease.
Shen XF; Huang P; Fox DA; Lin Y; Zhao ZH; Wang W; Wang JY; Liu XQ; Chen JY; Luo WJ
Neurotoxicology; 2016 Dec; 57():145-152. PubMed ID: 27663850
[TBL] [Abstract][Full Text] [Related]
30. Estrogen attenuates VEGF-initiated blood-retina barrier breakdown in male rats.
Chen X; Zhang M; Jiang C; Guo W; Liu H; Wei S
Horm Metab Res; 2011 Aug; 43(9):614-8. PubMed ID: 21823056
[TBL] [Abstract][Full Text] [Related]
31. Β-alanine and l-histidine transport across the inner blood-retinal barrier: potential involvement in L-carnosine supply.
Usui T; Kubo Y; Akanuma S; Hosoya K
Exp Eye Res; 2013 Aug; 113():135-42. PubMed ID: 23773890
[TBL] [Abstract][Full Text] [Related]
32. Exendin-4 alleviates retinal vascular leakage by protecting the blood-retinal barrier and reducing retinal vascular permeability in diabetic Goto-Kakizaki rats.
Fan Y; Liu K; Wang Q; Ruan Y; Ye W; Zhang Y
Exp Eye Res; 2014 Oct; 127():104-16. PubMed ID: 24910901
[TBL] [Abstract][Full Text] [Related]
33. Characterization of azurocidin as a permeability factor in the retina: involvement in VEGF-induced and early diabetic blood-retinal barrier breakdown.
Skondra D; Noda K; Almulki L; Tayyari F; Frimmel S; Nakazawa T; Kim IK; Zandi S; Thomas KL; Miller JW; Gragoudas ES; Hafezi-Moghadam A
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):726-31. PubMed ID: 18235021
[TBL] [Abstract][Full Text] [Related]
34. The cKit Inhibitor, Masitinib, Prevents Diabetes-Induced Retinal Vascular Leakage.
Kim SR; Im JE; Jeong JH; Kim JY; Kim JT; Woo SJ; Sung JH; Park SG; Suh W
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1201-6. PubMed ID: 26978025
[TBL] [Abstract][Full Text] [Related]
35. Cholinergic neural activity directs retinal layer-specific angiogenesis and blood retinal barrier formation.
Weiner GA; Shah SH; Angelopoulos CM; Bartakova AB; Pulido RS; Murphy A; Nudleman E; Daneman R; Goldberg JL
Nat Commun; 2019 Jun; 10(1):2477. PubMed ID: 31171770
[TBL] [Abstract][Full Text] [Related]
36. Endothelial Cell Transcytosis Assay as an In Vitro Model to Evaluate Inner Blood-Retinal Barrier Permeability.
Bora K; Wang Z; Yemanyi F; Maurya M; Blomfield AK; Tomita Y; Chen J
J Vis Exp; 2022 Jun; (184):. PubMed ID: 35758707
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-126 Reduces Blood-Retina Barrier Breakdown via the Regulation of VCAM-1 and BCL2L11 in Ischemic Retinopathy.
Bai X; Luo J; Zhang X; Han J; Wang Z; Miao J; Bai Y
Ophthalmic Res; 2017; 57(3):173-185. PubMed ID: 28076855
[TBL] [Abstract][Full Text] [Related]
38. Mechanisms Underlying Rare Inherited Pediatric Retinal Vascular Diseases: FEVR, Norrie Disease, Persistent Fetal Vascular Syndrome.
Le V; Abdelmessih G; Dailey WA; Pinnock C; Jobczyk V; Rashingkar R; Drenser KA; Mitton KP
Cells; 2023 Nov; 12(21):. PubMed ID: 37947657
[TBL] [Abstract][Full Text] [Related]
39. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
40. Newly-established in vitro inner BRB spheroids to elucidate retinal Ang2-linked substance transfer.
Yamamoto Y; Akanuma SI; Kon H; Endo H; Kubo Y; Hosoya KI
J Control Release; 2022 Nov; 351():8-21. PubMed ID: 36122894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
